COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,009 Articles (22,627 medRxiv, 8,382 bioRxiv)

Most recent first Previous |  Page 1620: Articles 16191-16200  | Next

Experiences of coping with the first wave of COVID-19 epidemic in Philadelphia, PA: Mixed methods analysis of a cross-sectional survey of worries and symptoms of mood disorders.
Burstyn, I., Huynh, T.
10.1101/2021.03.31.21254725 — Posted: 2021-04-06
Smoking and COVID-19: A two-sample Mendelian randomization study
Zheng, B.-K., Li, N.
10.1101/2021.03.31.21254730 — Posted: 2021-04-06
Reliable assessment of in vitro SARS-CoV-2 infectivity by a Rapid Antigen Detection Test
Korenkov, M., Poopalasingam, N., Madler, M., Vanshylla, K., Eggeling, R., Wirtz, M., Fish, I., Dewald, F., Gieselmann, L., Lehmann, C., Faetkenheuer, G., Gruell, H., Pfeifer, N., Heger, E., Klein, F.
10.1101/2021.03.30.21254624 — Posted: 2021-04-06
First-in-Human Trial of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine with Adjuvant of Aluminum Hydroxide and CpG 1018
Hsieh, S.-M., Liu, W.-D., Huang, Y.-S., Lin, Y.-J., Hsieh, E.-F., Lian, W.-C., Chen, C., Tai, I.-C., Chang, S.-C.
10.1101/2021.03.31.21254668 — Posted: 2021-04-06
Global-scale analysis and longitudinal assessment of COVID-19 incidence in the first six months
GHOSH, S., ROY, S. S.
10.1101/2021.03.31.21254739 — Posted: 2021-04-06
DRUL for School: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2
Frank, M., Blachere, N. E., Parveen, S., Hacisuleyman, E., Fak, J., Luna, J. M., Michailidis, E., Wright, S., Stark, P., Campbell, A. H., Foo, A., Sakmar, T. P., Huffman, V., Bergh, M., Goldfarb, A., Mansisidor, A., Patriotis, A. L., Palmquist, K. H., Poulton, N., Leicher, R., Vargas, C. D., Duba, I., Hurley, A., Colagreco, J. P., Pagane, N., Orange, D. E., Mora, K., Rakeman, J. L., Fowler, R. C., Fernandes, H., Lamendola-Essel, M. F., Didkovsky, N., Silvera, L., Masci, J., Allen, M., Rice, C. M., Darnell, R. B.
10.1101/2021.04.03.21254873 — Posted: 2021-04-06
Implementation of SARS-CoV-2 monoclonal antibody infusion sites at three medical centers in the United States: Strengths and challenges assessment to inform COVID-19 pandemic and future public health emergency use
Lambrou, A. S., Redd, J. T., Stewart, M. A., Rainwater-Lovett, K., Thornhill, J. K., Hayes, L., Smith, G., Thorp, G. M., Tomaszewski, C., Edward, A., Elias Calles, N., Amox, M., Merta, S., Pfundt, T., Callahan, V., Tewell, A., Scharf-Bell, H., Imbriale, S., Freeman, J. D., Anderson, M., Kadlec, R. P.
10.1101/2021.04.05.21254707 — Posted: 2021-04-06
Replication of LZTFL1 gene region as a susceptibility locus for COVID-19 in Latvian population.
Rescenko, R., Peculis, R., Ustinova, M., Ansone, L., Litvina, H. D., Terentjeva, A., Birzniece, L., Megnis, K., Kolesova, O., Rozentale, B., Viksna, L., Rovite, V., Klovins, J.
10.1101/2021.03.31.21254708 — Posted: 2021-04-06
Quantifying Face Mask Comfort
Koh, E., Ambatipudi, M., Boone, D. L., Luehr, J. B. W., Blaise, A., Gonzalez, J., Sule, N., Mooney, D. J., He, E. M.
10.1101/2021.03.31.21254723 — Posted: 2021-04-06
Efficient Maternal to Neonatal transfer of SARS-CoV-2 and BNT162b2 antibodies
Beharier, O., Plitman Mayo, R., Raz, T., Nahum Sacks, K., Schreiber, L., Suissa-Cohen, Y., Chen, R., Gomez-Tolub, R., Hadar, E., Gabbay-Benziv, R., Jaffe Moshkovich, Y., Biron-Shental, T., Shechter-Maor, G., Farladansky-Gershnabel, S., Yitzhak Sela, H., Benyamini-Raischer, H., Sela, N. D., Goldman-Wohl, D., Shulman, Z., Many, A., Barr, H., Yagel, S., Neeman, M., Kovo, M.
10.1101/2021.03.31.21254674 — Posted: 2021-04-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).